<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101701004</journal-id>
<journal-id journal-id-type="pubmed-jr-id">46235</journal-id>
<journal-id journal-id-type="nlm-ta">Birth Defects Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Birth Defects Res</journal-id>
<journal-title-group>
<journal-title>Birth defects research</journal-title>
</journal-title-group>
<issn pub-type="epub">2472-1727</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29251840</article-id>
<article-id pub-id-type="pmc">6476421</article-id>
<article-id pub-id-type="doi">10.1002/bdr2.1180</article-id>
<article-id pub-id-type="manuscript">EPAPA1510074</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Blood-Brain Barrier Development: Systems Modeling and Predictive
Toxicology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Saili</surname>
<given-names>Katerine S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zurlinden</surname>
<given-names>Todd J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schwab</surname>
<given-names>Andrew J.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silvin</surname>
<given-names>Aymeric</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Nancy C.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sidney Hunter</surname>
<given-names>E.</given-names>
<suffix>III</suffix>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ginhoux</surname>
<given-names>Florent</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knudsen</surname>
<given-names>Thomas B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>National Center for Computational Toxicology (NCCT); U.S.
Environmental Protection Agency, Office of Research &amp; Development; 109 T.W.
Alexander Drive, Research Triangle Park, NC 27711</aff>
<aff id="A2"><label>2</label>National Health and Environmental Effects Research
Laboratory (NHEERL); U.S. Environmental Protection Agency, Office of Research &amp;
Development; 109 T.W. Alexander Drive, Research Triangle Park, NC 27711</aff>
<aff id="A3"><label>3</label>Singapore Immunology Network (SIgN); Agency for Science,
Technology and Research (A*STAR) Singapore 138648</aff>
<aff id="A4"><label>4</label>Leidos, contractor to NCCT; 109 T.W. Alexander Drive,
Research Triangle Park, NC 27711</aff>
<author-notes>
<corresp id="CR1"><label>*</label>corresponding author: Thomas B. Knudsen, 109 T.W.
Alexander Drive (D-143-02), Research Triangle, Park, NC 27711, TEL:
919-541-9776; FAX: 919-541-1194, <email>knudsen.thomas@epa.gov</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P80">6. Conflict of interest statement</p>
<p id="P81">The authors declare no conflicts.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>22</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>109</volume>
<issue>20</issue>
<fpage>1680</fpage>
<lpage>1710</lpage>
<!--elocation-id from pubmed: 10.1002/bdr2.1180-->
<abstract id="ABS1">
<p id="P1">The blood-brain barrier (BBB) serves as a gateway for passage of drugs,
chemicals, nutrients, metabolites and hormones between vascular and neural
compartments in the brain. Here, we review BBB development with regard to the
microphysiology of the neurovascular unit (NVU) and the impact of BBB disruption
on brain development. Our focus is on modeling these complex systems. Extant
<italic>in silico</italic> models are available as tools to predict the
probability of drug/chemical passage across the BBB; <italic>in vitro</italic>
platforms for high-throughput screening and high-content imaging provide novel
data streams for profiling chemical-biological interactions; and engineered
human cell-based microphysiological systems provide empirical models with which
to investigate the dynamics of NVU function. Computational models are needed
that bring together kinetic and dynamic aspects of NVU function across gestation
and under various physiological and toxicological scenarios. This integration
will inform adverse outcome pathways to reduce uncertainty in translating
<italic>in vitro</italic> data and <italic>in silico</italic> models for use
in risk assessments that aim to protect neurodevelopmental health.</p>
</abstract>
<kwd-group>
<kwd>predictive toxicology</kwd>
<kwd>childrenâ€™s environmental health</kwd>
<kwd>neurovascular development</kwd>
<kwd>blood-brain barrier</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>